Product Description: Vepafestinib (TAS0953/HM06; compound 6) is a RET inhibitor (extracted from patent WO2019039439)[1]. Vepafestinib is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Applications: Cancer-Kinase/protease
Formula: C26H30N6O3
References: [1]Hayashi, Kohei, et al. FUSION PROTEIN OF DCTN1 PROTEIN WITH RET PROTEIN. WO2019039439.